Wilson?s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson?s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson?s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson?s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
This report aims to provide a comprehensive presentation of the global market for Wilson's Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease Drugs. This report contains market size and forecasts of Wilson's Disease Drugs in global, including the following market information:
Global Wilson's Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Wilson's Disease Drugs market was valued at US$ 210 million in 2022 and is projected to reach US$ 308.5 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Wilson?s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson?s disease. Penicillamine is the most successful drug used for the treatment of Wilson?s disease. Wilson?s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson?s disease is Drugs?Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
We surveyed the Wilson's Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wilson's Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Hepatic
Neuropsychiatric
Ophthalmic
Others
Global Wilson's Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Wilson's Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Wilson's Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Wilson's Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wilson's Disease Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Wilson's Disease Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kadmon Holdings, Inc.
Merck & Co.
Teva Pharmaceutical Industries Limited
Tsumura & Co.
Valeant Pharmaceuticals International, Inc.
VHB Life Sciences, Inc.
Wilson Therapeutics AB (Alexion)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Wilson's Disease Drugs, market overview.
Chapter 2: Global Wilson's Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Wilson's Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Wilson's Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Wilson's Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Wilson's Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Wilson's Disease Drugs Overall Market Size
2.1 Global Wilson's Disease Drugs Market Size: 2022 VS 2029
2.2 Global Wilson's Disease Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Wilson's Disease Drugs Players in Global Market
3.2 Top Global Wilson's Disease Drugs Companies Ranked by Revenue
3.3 Global Wilson's Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Wilson's Disease Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Wilson's Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Wilson's Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Wilson's Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Wilson's Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Wilson's Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 Hepatic
4.1.3 Neuropsychiatric
4.1.4 Ophthalmic
4.1.5 Others
4.2 By Type - Global Wilson's Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Wilson's Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Wilson's Disease Drugs Revenue, 2024-2029
4.2.3 By Type - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Wilson's Disease Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Wilson's Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Wilson's Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Wilson's Disease Drugs Revenue, 2024-2029
5.2.3 By Application - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Wilson's Disease Drugs Market Size, 2022 & 2029
6.2 By Region - Global Wilson's Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Wilson's Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Wilson's Disease Drugs Revenue, 2024-2029
6.2.3 By Region - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Wilson's Disease Drugs Revenue, 2018-2029
6.3.2 US Wilson's Disease Drugs Market Size, 2018-2029
6.3.3 Canada Wilson's Disease Drugs Market Size, 2018-2029
6.3.4 Mexico Wilson's Disease Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Wilson's Disease Drugs Revenue, 2018-2029
6.4.2 Germany Wilson's Disease Drugs Market Size, 2018-2029
6.4.3 France Wilson's Disease Drugs Market Size, 2018-2029
6.4.4 U.K. Wilson's Disease Drugs Market Size, 2018-2029
6.4.5 Italy Wilson's Disease Drugs Market Size, 2018-2029
6.4.6 Russia Wilson's Disease Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Wilson's Disease Drugs Market Size, 2018-2029
6.4.8 Benelux Wilson's Disease Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Wilson's Disease Drugs Revenue, 2018-2029
6.5.2 China Wilson's Disease Drugs Market Size, 2018-2029
6.5.3 Japan Wilson's Disease Drugs Market Size, 2018-2029
6.5.4 South Korea Wilson's Disease Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Wilson's Disease Drugs Market Size, 2018-2029
6.5.6 India Wilson's Disease Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Wilson's Disease Drugs Revenue, 2018-2029
6.6.2 Brazil Wilson's Disease Drugs Market Size, 2018-2029
6.6.3 Argentina Wilson's Disease Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Wilson's Disease Drugs Revenue, 2018-2029
6.7.2 Turkey Wilson's Disease Drugs Market Size, 2018-2029
6.7.3 Israel Wilson's Disease Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Wilson's Disease Drugs Market Size, 2018-2029
6.7.5 UAE Wilson's Disease Drugs Market Size, 2018-2029
7 Wilson's Disease Drugs Companies Profiles
7.1 Kadmon Holdings, Inc.
7.1.1 Kadmon Holdings, Inc. Company Summary
7.1.2 Kadmon Holdings, Inc. Business Overview
7.1.3 Kadmon Holdings, Inc. Wilson's Disease Drugs Major Product Offerings
7.1.4 Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.1.5 Kadmon Holdings, Inc. Key News & Latest Developments
7.2 Merck & Co.
7.2.1 Merck & Co. Company Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. Wilson's Disease Drugs Major Product Offerings
7.2.4 Merck & Co. Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck & Co. Key News & Latest Developments
7.3 Teva Pharmaceutical Industries Limited
7.3.1 Teva Pharmaceutical Industries Limited Company Summary
7.3.2 Teva Pharmaceutical Industries Limited Business Overview
7.3.3 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceutical Industries Limited Key News & Latest Developments
7.4 Tsumura & Co.
7.4.1 Tsumura & Co. Company Summary
7.4.2 Tsumura & Co. Business Overview
7.4.3 Tsumura & Co. Wilson's Disease Drugs Major Product Offerings
7.4.4 Tsumura & Co. Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.4.5 Tsumura & Co. Key News & Latest Developments
7.5 Valeant Pharmaceuticals International, Inc.
7.5.1 Valeant Pharmaceuticals International, Inc. Company Summary
7.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Major Product Offerings
7.5.4 Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.5.5 Valeant Pharmaceuticals International, Inc. Key News & Latest Developments
7.6 VHB Life Sciences, Inc.
7.6.1 VHB Life Sciences, Inc. Company Summary
7.6.2 VHB Life Sciences, Inc. Business Overview
7.6.3 VHB Life Sciences, Inc. Wilson's Disease Drugs Major Product Offerings
7.6.4 VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.6.5 VHB Life Sciences, Inc. Key News & Latest Developments
7.7 Wilson Therapeutics AB (Alexion)
7.7.1 Wilson Therapeutics AB (Alexion) Company Summary
7.7.2 Wilson Therapeutics AB (Alexion) Business Overview
7.7.3 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Major Product Offerings
7.7.4 Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue in Global Market (2018-2023)
7.7.5 Wilson Therapeutics AB (Alexion) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Wilson's Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Wilson's Disease Drugs Market Drivers in Global Market
Table 3. Wilson's Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Wilson's Disease Drugs in Global Market
Table 5. Top Wilson's Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Wilson's Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Wilson's Disease Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Wilson's Disease Drugs Product Type
Table 9. List of Global Tier 1 Wilson's Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Wilson's Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Wilson's Disease Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Wilson's Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Wilson's Disease Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Wilson's Disease Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Wilson's Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Wilson's Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Wilson's Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Wilson's Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Kadmon Holdings, Inc. Company Summary
Table 31. Kadmon Holdings, Inc. Wilson's Disease Drugs Product Offerings
Table 32. Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Kadmon Holdings, Inc. Key News & Latest Developments
Table 34. Merck & Co. Company Summary
Table 35. Merck & Co. Wilson's Disease Drugs Product Offerings
Table 36. Merck & Co. Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co. Key News & Latest Developments
Table 38. Teva Pharmaceutical Industries Limited Company Summary
Table 39. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Product Offerings
Table 40. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceutical Industries Limited Key News & Latest Developments
Table 42. Tsumura & Co. Company Summary
Table 43. Tsumura & Co. Wilson's Disease Drugs Product Offerings
Table 44. Tsumura & Co. Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Tsumura & Co. Key News & Latest Developments
Table 46. Valeant Pharmaceuticals International, Inc. Company Summary
Table 47. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Product Offerings
Table 48. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Valeant Pharmaceuticals International, Inc. Key News & Latest Developments
Table 50. VHB Life Sciences, Inc. Company Summary
Table 51. VHB Life Sciences, Inc. Wilson's Disease Drugs Product Offerings
Table 52. VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. VHB Life Sciences, Inc. Key News & Latest Developments
Table 54. Wilson Therapeutics AB (Alexion) Company Summary
Table 55. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Product Offerings
Table 56. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Wilson Therapeutics AB (Alexion) Key News & Latest Developments
List of Figures
Figure 1. Wilson's Disease Drugs Segment by Type in 2022
Figure 2. Wilson's Disease Drugs Segment by Application in 2022
Figure 3. Global Wilson's Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Wilson's Disease Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Wilson's Disease Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Wilson's Disease Drugs Revenue in 2022
Figure 8. By Type - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Wilson's Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Wilson's Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 16. US Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 28. China Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Wilson's Disease Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Wilson's Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Kadmon Holdings, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceutical Industries Limited Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Tsumura & Co. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Valeant Pharmaceuticals International, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. VHB Life Sciences, Inc. Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Wilson Therapeutics AB (Alexion) Wilson's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
